Replies to post #480923 on Anavex Life Sciences Corp (AVXL)

[georgejjl]

Doc328: Do you believe that the following is in general true or false???

Alzheimer's disease is easier to treat at the earliest stage possible.

See the image below to understand why this is true.



The above is especially true if you are targeting upstream MOA with precision medicine.

The Anavex Blarcamesine Phase 2b/3 trial is for early stage Alzheimer's disease with baseline MMSE scores of 20 to 28 inclusive

Prevention of Alzheimer's disease via Blarcamesine or Anavex 3-71 would be the earliest stage possible.

Good luck and GOD bless

[georgejjl]

Read the January 2025 Corporate Presentation for Anavex Life Sciences

https://www.anavex.com/_files/ugd/79bcf7_da38b4e0ad4b4ff888363403e3962ef2.pdf

Good luck and GOD bless,

[catdaddy]

So, what is your job that is so dependent on understanding biotech?

[Thehubby]

I do not understand all the intricacies of the internal combustión engine, but that does not preclude me from knowing how to drive

[boi568]

There are dozens of people whose jobs depend on understanding biotech who recently went on record completely disagreeing with you. So it's clear that having a job that depends on understanding biotech does not, itself, tell you who is right here about Anavex.

[samk]

Really? Or this is just a sarcastic joke?

[sab63090]

Yes, I've been fooled enough, but certainly remember people who promise and refuse to be clear and honest! Missling promised to showcase OLE, but only wound up getting a spanking in price!

He, again, pushed the data down the road to April.Apparently, the market responded.

The drop was quite big considering that this was his opportunity to reveal everything the market wanted to hear....my impression was that he presented poorly and I still feel the audience was not large.

Well, at least my granddaughter's boyfriend and his mother seemed to take their shock of his stolen car & possessions pretty well before returning to the university...she brought her car for her son to use and her boyfriend (a doctor) drove a rental to travel back to New Hampshire. Nice people & we came together at our home...went well.

[WolfofMia]

Ofcourse you know ppl on this board more than ppl on this board know ppl on this board.

Give me a break lmao.

The disqualification team latest example.

We rather trust the REAL PUBLIC scientist over any PRETENDER!

[Hoskuld]

As hubby wrote, it is not important to be a biotech expert to see that 2-73 is almost certain to be approved for AD or that 3-71 is looking pretty good so far for schizophrenia. We all rely on people with more expertise that we have to make good decisions. 58 experts - all of whom know more about the pathology and treatment of AD patients than we do (even those of us whose families have suffered) - tell us 2-73 is a game-changer. The OLE confirms it. The EMA has accepted the MAA application which is close to a blessing. The EU member countries are negotiating pricing now.

It does help to understand the various areas of function in biotech in order to assess operational risks and market opportunity, and to understand clinical process to assess likelihood of success. I have first hand experience with nearly everything except for drug product sales, business development (M&A, in/out-licensing, partnerships), real estate, and legal. I don't think that you or investor and a couple of other posters here are barking up the right trees in general - and don't really understand why you participate here if you don't really want to be constructive.